Gerhard Zenke
Novartis (Switzerland)(CH)Novartis Institutes for BioMedical Research
Publications by Year
Research Areas
Signaling Pathways in Disease, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, T-cell and B-cell Immunology, Toxin Mechanisms and Immunotoxins
Most-Cited Works
- → SDZ RAD, A NEW RAPAMYCIN DERIVATIVE(1997)536 cited
- → Interleukin-3 is a differentiation factor for human basophils(1989)215 cited
- → Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions(1995)173 cited
- → The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation(2009)159 cited
- → Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110. I. Taxonomy, Fermentation, Isolation and Biological Activity.(1999)146 cited
- → Discovery of 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes(2009)133 cited